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Abstract Genome-wide association studies (GWAS)
have been successful in identifying loci associated with a
wide range of complex human traits and diseases. Up to
now, the majority of GWAS have focused on European
populations. However, the inclusion of other ethnic groups
as well as admixed populations in GWAS studies is rapidly
rising following the pressing need to extrapolate findings to
non-European populations and to increase statistical power.
In this paper, we describe the methodological steps sur-
rounding genetic data generation, quality control, study
design and analytical procedures needed to run GWAS in
the multiethnic and highly admixed Generation R Study, a
large prospective birth cohort in Rotterdam, the Nether-
lands. Furthermore, we highlight a number of practical
considerations and alternatives pertinent to the quality
control and analysis of admixed GWAS data.
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Introduction
Genome-wide association studies (GWAS) analyze a large
number of single nucleotide polymorphism (SNPs) across
the genome in a large number of samples, aiming to
identify loci associated with complex traits at the popula-
tion level. Since 2007, well-designed studies have been
able to comprehensively test common genetic variation
across the genome [1]. Up to now, at least 11,680 SNPs
have been robustly associated with one or more complex
traits, providing biological insight in traits as different as
Alzheimer’s disease, prostate cancer, inflammatory bowel
disease, obesity, stroke, diabetes, asthma, height, choles-
terol levels and bone mineral density, to name only few
examples of the successful performance of this approach
[2].
Variants discovered by GWAS typically have small
effects which is why minor sources of systematic or ran-
dom error can lead to false positive associations or can
mask real effects (false negative associations). In order to
avoid bias, it is necessary to closely control the processes
underlying the production of GWAS data, extending from
laboratory processes (data generation) to imputation. It is
also necessary to conduct statistical analyses, which
incorporate factors into the models known to influence the
trait of interest, as well as being appropriate to the char-
acteristics of the study design.
Ethnicity is a confounder of epidemiological studies
which incorporates cultural, geographical and biological
dimensions. In the GWAS context spurious associations
between genetic variants and a trait of interest occur when
both allele frequencies and differences in trait distributions
(disease prevalence or magnitude of quantitative traits),
vary across ethnicities. From this perspective, adequate
correction for potential population stratification is required
for successful identification of genetics determinants of
complex traits and diseases.
To date, GWAS have mainly focused on populations of
European ancestry. Consequently, having another ethnic
background is a common reason for exclusion of GWAS
samples. As an illustration, from the 1734 GWAS papers
indexed in the GWAS catalogue, 66 % included only
individuals from European ancestry, 34 % included Non-
Europeans only (most of those carried out in Asian popu-
lations), and 12 % included both Europeans and Non-
European individuals [3]. Moreover, big consortia efforts
such as Cohorts for Heart and Aging Research (CHARGE)
or the Genetic Investigation of Anthropometric Traits
(GIANT) have focused primarily on European populations,
while efforts driven in populations of diverse ethnic
background are of modest sample sizes. However, the
inclusion of multiethnic and/or admixed populations in the
analysis of GWAS can actually result in additional power.
Firstly, larger datasets (representing higher power) can be
assembled when the ancestry criterion is not used for
sample exclusion. Keeping such ‘‘ethnic outliers’’ in the
study also represents a better use of resources considering
the logistic and burden behind sample collection and
genotyping, and their associated costs. Secondly, the
European-only approach has little power to detect asso-
ciation for genetic variants segregating at low frequency in
European populations and statistical power can be gained if
those variants are more common in other ancestries in-
cluded in the analysis [4]. Some examples are provided by
Fu et al., who describe variants associated with type 2
diabetes mapping to UBE2E2 and KCNQ1 that have higher
frequencies in East Asians [minor allele frequency (MAF)
of 0.22 and 0.38, respectively] as compared with Eur-
opeans (MAF of 0.093 and 0.08, respectively) [5]. Simi-
larly, Wu et al. showed examples of ethnic specificity in
variants associated with lipid levels mapping to APOA5
and APOB. These very rare variants identified in African-
Americans were not detected in either East Asian or Eur-
opean populations [6]. Further, (rare) variants specific to a
subpopulation (e.g. a diabetes susceptibility variant arising
in Native-Americans) can be identified in a derived highly
admixed population (i.e. Mexicans) as having the largest
effect [7]. In addition, population admixture, due to inter-
breeding of individuals from different origins, would have
brought together genomes from continental populations,
which are a product of genetic drift and different selective
pressures. Following this line of reasoning, it is expected
that recently admixed populations are likely to harbor a
larger number of genetic variants than the original popu-
lations they come from [8]. Theoretically, this will result in
a higher yield in the discovery of genetic determinants of
complex traits. Another important genetic approach, sui-
table in admixed population, to identify disease risk var-
iants is admixture mapping, which is powerful when the
ancestral populations differ both in allele frequencies and
disease prevalence. Then, in the vicinity of a disease locus,
an affected individual should have a higher proportion of
alleles inherited from the most affected ancestral popula-
tion [9].
As GWAS worldwide are expanding to include multi-
ethnic and admixed populations, we describe here the steps
used for genetic data generation, study design and analy-
tical procedures applied in the Generation R Study. The
Generation R Study is a population-based prospective
cohort following children and their mothers from fetal life
onwards, which comprises a multiethnic population,
including a high proportion of highly admixed individuals.
We here mainly focus on how this approach can allow
analyzing the whole set of individuals independent of
genetic background as a mean to increase sample size and
power to identify loci underlying complex traits and
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diseases. The different considerations described here can
be applied to other multiethnic studies, particularly those of
admix nature such as Hispanics or African Americans.
Methods
Study population
The Generation R Study is a multi-ethnic population-based
prospective cohort study, spanning from fetal life until
young adulthood, designed to identify early environmental
and genetic causes of normal and abnormal growth,
development and health during fetal life, childhood and
young adulthood. Study design, data collection in prenatal
and postnatal phases, and ethical issues of this study have
been previously described in detail [10]. The Generation R
Study is conducted in Rotterdam, the Netherlands, within a
multi-cultural metropolitan area. The study area includes
inhabitants of approximately 150 different ethnicities [11].
Pregnant women with a delivery date between April 2002
and January 2006 were informed about the study and
provided written informed consent through their prenatal
care provider during their first visit of the pregnancy. The
medical ethics committee of Erasmus University Medical
Center approved the study. In total, 9778 mothers were
enrolled in the study.
The ethnic background of the children was defined by
the parents’ country of birth, which was obtained by
questionnaire. The participating child was defined as of
non-Dutch ethnic origin if one of her/his parents was born
abroad, and further classified using a socio-demographic
definition as described by Statistics Netherlands [11]. If
both parents were born abroad, the country of birth of the
mother decided the classification of the ethnic background
of the child. The ethnic background of the mother and
partner were obtained in the same manner, based on their
parents’ (the child’s grandparents) country of birth.
Sample collection, biobanking and genotyping
Blood samples of the children were collected from the
umbilical cord at birth. Where an umbilical cord blood
sample could not be collected at birth, a blood sample was
obtained by venipuncture during the child’s visit to the
research center at a mean age of 6 years. All samples were
coded with a unique laboratory number. Umbilical cord
samples were collected in 10 ml EDTA tubes and stored
immediately at -80 C, while samples obtained by veni-
puncture were collected in 5 ml EDTA tubes and stored
directly after transport at -20 C. DNA was extracted
manually from white blood cells using the Qiagen Flex-
iGene Kit (Qiagen Hilden, Germany). Normalisation and
further processing of the DNA samples were performed on
a Caliper ALH3000 pipetting robot. A detailed description
of the Generation R Biobank has been previously published
[12].
Genotyping was performed using Illumina HumanHap
610 or 660 Quad chips—depending on collection time—
following manufacturer protocols, and intensities were
obtained from the BeadArray Reader. Genotype calling
was performed on normalized intensities using the Gene-
call module from the Illumina Genome Studio software
version 1.1.0.28426. A no-call threshold of 0.15 was
applied to a manufacturer-provided cluster file. Illumina
Genome Studio provides a quality metric used to identify
low-quality samples and, we used a threshold of 97.5 % for
exclusion of samples.
DNA quality control (QC)
The two Genome Studio projects (one each for the
HumanHap 610 array and for the 660 array), were merged
using SNPs common to both arrays. The QC procedures
were applied to the genotyped data using PLINK [13] in
two phases: marker- and sample-based.
Marker QC included filters for: (1) marker call rate
(calling \0.2 – \0.05, --geno option), checked in two
rounds, the initial with a threshold of 80 % and the second
one more stringent (95 %), after inspection of sample
quality, (2) minor allele frequency (MAF B 0.001, --maf
option), (3) differential missingness between the two pro-
jects (P \ 1 9 10-7, --test-missing option) and (4)
deviation from Hardy–Weinberg equilibrium proportion
(P \ 10-7 --hwe option). Sample QC included: (1)
duplicate detection (PLINK option IBS = 1), (2) sex dis-
cordance rates (--check-sex option), comparing the
reported sex of each participant with the sex predicted by
the genetic data (expected chromosome X heterozygosity).
When results were inconclusive, the Genome Studio plots,
log R ratios and B-allele frequencies, for both X and Y
chromosomes were inspected. (3) Genotype call rate
(\0.05 – \0.025--mind option) checked in two rounds,
the initial with a threshold of 95 % and the second one
more stringent (97.5 %), after inspection of marker quality
and (4) high heterozygosity rate, over 4 SD of the mean
heterozygosity of all samples (--het option). The step by
step summary of the applied QC pipeline is presented in
Fig. 1, and Online Resources 1 and 2.
Population sub-structure and family relationships
Additional sample QC assessments were applied to deter-
mine genetic-based ethnic background and to identify
potential family relationships.
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Genetic ancestry
To characterize the genetic ancestry of the children in the
Generation R Study, all samples passing QC procedures
were merged with the three genotyped panels from the
HapMap Phase II release 22 build 36 including: North-
western Europeans (CEPH collection or CEU), Sub-
saharan West Africans (Yoruba or YRI) and Asians (Han
Chinese from Beijing or CHB, and Japanese from Tokyo or
JPT) [14, 15] using only independent autosomal SNPs
(r2 [ 0.05). In the merged dataset, pairwise identity-by-
state (IBS) relations were calculated for each pair of indi-
viduals (representing the average proportion of alleles
shared by those individuals) using PLINK (--genome
option). In addition, principal axes of variation [or so-
called genomic components equivalent to Principal Com-
ponents (PCs)] were derived from this IBS matrix by multi-
dimensional scaling (MDS), to characterize the variability
present in the data using few variables (PLINK --
cluster --mds-plot). Participants were defined as
being of non- Northwestern European ancestry when
deviating more than 4 standard deviations (SDs) from the
CEU panel mean value in any of the first four genomic
components.
Sample relatedness
To identify cryptic family relationships within the Gen-
eration R samples, we first removed the HapMap samples,
recalculated the IBS matrix including only participants of
the Generation R Study and then determined pairwise, the
proportion of shared IBS alleles. By using this information
and the population allele frequency, PLINK is able to
estimate the number of these alleles coming from the same
ancestor, known as IBD (identity-by-descent), using the
methods of moments [13]. These familial relationships
detected using PLINK, were validated post hoc using the
recently released software REAP (Relatedness Estimation
in Admixed Populations). REAP estimates IBD proportions
in a similar way than PLINK. Nonetheless, it uses
Fig. 1 Flowchart overview of the entire GWAS QC process. Quality control of all samples from Generation R-1 and Generation R-2 after
merging of the projects. Red font denotes exclusion of either SNPs or samples from the dataset in the different QC steps. (Color figure online)
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individual-specific allele frequencies that are calculated by
conditioning on estimated individual genome-wide ances-
try [16].
Genotype imputation
A two-step genotype imputation, comprising a phasing step
to resolve the haplotypes of the genotyped markers (using
MACH software) and an imputation step in which unmapped
SNPs are imputed to a reference panel (using Minimac
software), was applied to the GWAS genotyped dataset after
QC. Data was divided in marker sets across chromosomes to
be processed using a parallel computing cluster. Thus far,
two different reference panels have been used to impute the
Generation R data: (a) HapMap Project Phase II Release 22,
build 36 phasing and (b) 1000 Genomes Project (phase III
release version), build 37 phasing. For the phasing of the
haplotypes we used the standard parameters recommended
by the MACH/minimac developers (http://genome.sph.
umich.edu/wiki/Minimac) consisting of 20 iterations of the
Markov sampler and 200 states (number of haplotypes that
should be considered when updating each individual). Par-
allelization was achieved by splitting jobs on chunks across
chromosomes. The window size was 2100 markers, of which
100 were flanking markers, when using assembly build 36,
and a window size of 2500 markers, using 500 as flanking
markers when using assembly build 37. Imputations were
performed following the same chunking strategy of paral-
lelization as mentioned for the phasing step. To evaluate
genotype imputation quality we used the MACH r-squared
(Rsq), metric based on the ratio of the empirically observed
variance of the allele dosage to the expected binomial var-
iance p(1 - p), assuming Hardy–Weinberg equilibrium,
where p is the observed allele frequency. When imputations
hold adequate information for predicting the unobserved
genotypes from the observed haplotype backgrounds, this
ratio should be distributed around unity [17]. By consensus
an Rsq [ 0.3 has been used to define sufficiently good
quality for analysis [18].
HapMap imputations
Imputations of autosomal chromosomes to HapMap used
all haplotypes available from Phase 2 of the International
HapMap Project reference panel, in the so-called ‘‘cos-
mopolitan approach’’. This combined reference panel
includes 210 individuals from the CEU, YRI and CHB/JPT
panels [15].
1000 Genomes imputations
A second round of imputations was performed using 1000
Genomes (1KG) data—phase 3 release (http://www.sph.
umich.edu/csg/abecasis/MACH/download/1000G.2012-03-
14.html), which comprises the genomes of 1092 indivi-
duals from 14 populations [19]. We employed the same
parameters as described for the phasing procedure in build
37, and included autosomal and chromosome X markers.
Chromosome X imputations were performed separately for
males and females.
Genome wide association analysis in the Generation R
Study
For illustration of possible pitfalls when using an admixed
population, association analyses in the Generation R Study
were performed with and without adjustment for population
substructure. Additionally, we evaluated the distribution of
the participant’s ethnicity along the genomic components,
in order to assess the adequacy of questionnaire-based
ethnicity to correct for population structure in the associa-
tion models. Finally, we contrasted the two most common
approaches used for correction of population stratification:
(1) the traditional method of inclusion of genomic compo-
nents as covariates in the association model, and (2) linear
mixed models, as implemented in the publicly available
software, Efficient Mixed-Model Association eXpedited
(EMMAX) [20]. The genome-wide significance (GWS)
threshold for the association was established at
P \ 5 9 10-8. For illustration, we present here examples
of association results in the whole Generation R population
obtained for two model phenotypes: (1) the dichotomous
red hair pigmentation (a highly stratified trait) and (2) the
continuous bone mineral density measured at the skull. For
the former example (n = 5731), logistic association ana-
lyses ran on directly genotyped markers were corrected by
four genomic components. Additionally, we used the two
imputed datasets—HapMap and 1KG—to show the fine
mapping resolution improvement of the genome-wide sig-
nal. For the latter skull BMD analyses (n = 4086), linear
association using HapMap imputed data including twenty
genomic components as covariates in the model. Further
details on collection and analysis of this phenotype have
been reported elsewhere [21]. For further illustration, we
ran GWAS for skull BMD with equal sample sizes
(n = 1909) in both the non-European and a randomly
selected sample of the European subgroup of the Generation
R Study, adjusting for 20 genomic components and com-
pared results for rs13223036, reported as the top-hit in a
meta-analysis of more than 9000 kids mainly from Eur-
opean ancestry [21].
All linear and logistic models were ran using the MACH
packages (http://www.unc.edu/*yunmli/software.html) as
available in the web-based tool GRIMP, which facilitates
high-speed analysis of large imputed datasets making use
of computational grid infrastructures [22].
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Results
Study population
A summary of the ethnic classification based upon ques-
tionnaire of the 9749 children participating in the Gen-
eration R Study is presented on Online Resource 3. Ethnic
classification was missing in 6.7 % of the population. The
largest ethnic groups in the cohort were of Dutch (57 %),
other European (7.4 %), Turkish (7.4 %), Surinamese
(7.3 %), and Moroccan (6.4 %).
Sample collection, biobanking and genotyping
At birth, 5908 samples were obtained from 30 ml cord blood
(Generation R-1). Additionally, 320 samples were drawn dur-
ing the visit to the research center at age 6 years (Generation
R-2). Of the DNA samples from the collection of Generation
R-1, 5815 (98.4 %) were genotyped using the Illumina
HumanHap 610 Quad chip [including 620,901 markers,
representing 592,532 SNPs and 28,369 copy number variation
(CNV) probes]. The 1.6 % of samples not genotyped were
discarded either for low quantity and/or low concentration of
DNA in the stock solution as well as possible unresolved
sample swaps. The extra 320 DNA samples in Generation R-2,
were genotyped with the Illumina HumanHap 660 Quad chip
(comprising 657,366 markers, 561,490 SNPs and 95,876 CNV
probes). The genotype data were exported on forward strand for
both collections. A total of 178 samples with genotyping rates
lower than 97.5 % (Genome Studio sample call rate), likely
arising due to low DNA quality, array problems or poor per-
formance of agents, were excluded from the final projects
(Generation R-1 and Generation R-2 sets).
DNA quality control
Marker QC
CNVs reported in the manifests of the arrays, together with
SNPs which could not be called in at least 95 % of the
samples or with a MAF B 0.001, were eliminated (Online
Resources 1 and 2) before merging the Generation R-1 and
Generation R-2 sets. The combined dataset, merged using
only SNPs common to both platforms (n = 5809), con-
sisted of 549,511 SNPs. No SNP was excluded in any of
the two call-rate inspections. One hundred and ninety-five
SNPs were removed due to differential missingness,
addressing possible bias induced by batch effects between
the sets. Improvements to our quality control pipeline could
be implemented, as to have more stringent standards. For
example, although PLINK will report alleles incompat-
ibilities when merging datasets, these would not be
detectable in case of palindromic SNPs (A/T and G/C).
Therefore, since strand issues would not be detected for
these type of SNPs checking allele frequencies before
merging is strongly recommended. In addition, 30,971
SNPs were excluded for deviations from Hardy–Weinberg
equilibrium (HWE) proportions (P \ 1 9 10-7). While
other causes of deviation exist, failure of this test is highly
indicative of genotyping errors at a given marker [23].
Sample QC
Unique laboratory codes together with an anonymous per-
son-unique study code were compared in order to identify
duplicates. Fifteen duplicated samples were removed from
analysis (10 from the Generation R-1 set and 5 from the
Generation R-2 set). Sex inconsistencies were flagged by
PLINK in 60 samples. Ten of them had incompatible sex data
while the others were assessed as ambiguous. After revision
of Genome Studio plots (Online Resource 4), we identified
discrepancies for 15 of those samples. In total, 25 samples
were excluded during this sex check. A sample genotyped
call rate test, based on the remaining SNPs after merging
projects, resulted in no samples exclusion. We found no
individual samples with excess of heterozygosity of more
than 4 SDs above the mean heterozygosity value of all
samples, thus the presence of sample cross-contamination
was unlikely. However, reduced heterozygosity (-4 SDs)
was identified in 34 samples, possibly as result of the mul-
tiethnic background of the samples. Excess of homozygosity
is typically seen in individuals from genetic isolates with
large stretches of linkage disequilibrium (LD) or in popula-
tions with substructure, in which there is partial admixture as
result of non-random mating, as is the case in the Generation
R Study [24, 25].
Population sub-structure
Genetic ancestry
Generation R and the three HapMap panels were merged
based on a common set of 36,845 independent (LD-pruned)
autosomal SNPs. After calculation of pairwise IBS genetic
distances between all individuals, we derived genomic
components, summarizing the structure of the data into
main genomic components explaining the genetic variation
(Fig. 2). Approximately 50.5 % of the samples deviated
more than 4 SDs from the mean CEU panel cluster on the
main four components and were classified as of ‘‘Non-
Northwestern European’’ origin. A previous release of the
Generation R data from 2009, included only individuals
whose samples were collected at birth, and who were
classified as of Northwestern European origin (N = 2661)
following the same steps mentioned above, and has been
used in some publications [10, 26, 27].
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Cryptic family relatedness
Two-hundred and eighty-nine possible pairwise sib-ships
were found by IBS-sharing using PLINK
(0.35 \ PI_HAT \ 1). Sixteen pairs of individuals shared
two alleles at every locus corresponding either to mono-
zygotic twins or a single sample processed twice. Twelve of
these relations were conflicting with the registry, and thus
most likely correspond to the same sample being processed
twice. In these cases both samples were removed from the
dataset. The four remaining pairs were twins when traced
back to registries. For these true twin pairs, the sample with a
lower call rate was removed from the dataset. First-degree
relationships discrepant with registry (13 samples) identified
using PLINK were not initially excluded. Nevertheless, they
were excluded after confirmation by REAP. Visualization of
kinship coefficients obtained from REAP revealed that
Generation R participants are (to a large extent) unrelated.
Sibling pairs are represented by the small peak around a
kinship coefficient of 0.25. Yet another peak (0.025\kinship
coefficient \0.0635) evidence the presence of third and
fourth degree related individuals (Online Resource 5).
Related individuals were not removed from the dataset to
allow exclusion/inclusion in association analyses to be done
specifically by phenotype availability. In addition, one more
individual was recently removed for retracted informed
consent. In summary, the current GWAS collection for the
Generation R Study consists of samples from 5732 children.
Genotype imputation
HapMap imputations
Using the three HapMap panels combined 3,021,329 SNPs
were imputed. The MAF distribution of imputed SNPs is
shown in Fig. 3. The mean Rsq for all the imputed data was
0.883, (median 0.972, IQR = 0.127); when markers with
MAF \ 0.01 were excluded (comprising 313,593 SNPs or
10.38 % of the markers), the mean Rsq was 0.914, (median
0.979, IQR = 0.083). Figure 3a, b shows how the increase
of Rsq is proportional to the increase in the MAF of the
markers. When grouping the markers into MAF bins, 83 %
of the SNPs with MAF \ 0.01 achieved sufficient quality,
while for the other bins more than 95 % of the SNPs were
well imputed. Nonetheless, there is a broad range of quality
scores for SNPs in each MAF bin. Statistical dispersion is
decreasing with MAF as seen by the interquartile range
represented by the size of the box in each bin. Patterns of
imputation quality by chromosome are shown in Online
Resource 6. In general, larger chromosomes tended to be
better imputed. Imputation quality was visually checked
across chromosomes and the only notorious fall in Rsq was
at centromeres and extremes of the telomeres, where the
density of markers is low. Markers on the sex chromo-
somes were not imputed to the HapMap reference panel.
1KG imputation
We were able to impute 30,072,738 autosomal variants
using the 1KG reference panel, in which 28,681,763 are
SNPs and 1,390,975 are insertion/deletions. The mean Rsq
for all variants was 0.574 (median 0.622, IQR = 0.636);
when markers with MAF \ 0.01 were excluded (com-
prising 18,804,120 SNPs or 62.52 % of the markers), the
mean Rsq increased to 0.815 (median 0.929,
IQR = 0.244). Figure 4 shows an assessment of imputa-
tion accuracy by MAF. Although imputation quality was
poor in the lower spectrum of allele frequencies
(MAF \ 0.05), 15,164,960 markers had an Rsq C 0.3 and
were suitable for analysis. Moreover, the number of mar-
kers comprising bins of common frequency (6,894,397
markers with MAF [ 0.05) is much lower than the number
Fig. 2 Genetic substructure of
the Generation R Study. Two-
dimensional plots from MDS
analyses of the Generation R
Study and the three initial
Panels form the HapMap
Project. Left panel First two
components explaining most of
the variability of the data. Right
panel Third and fourth
components explaining some of
the remaining data variability
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of markers comprising bins of low frequency (23,178,341
markers with MAF \ 0.05), which usually have low
imputation quality. Online Resource 6 summarizes the
performance of the imputation per chromosome. The
number of SNPs imputed on chromosome X was
1,264,877, of which 903,868 (71.5 %) were rare
(MAF \ 0.005). As expected, quality was not as high as
for the autosomal chromosomes, as a consequence of the
lower number of haplotypes contributed by men in this
chromosome. Considering markers of sufficient imputation
quality (Rsq C 0.3) on the autosomal chromosomes only,
the 1KG imputation resulted in 18,874,123 more markers
than those arising from the HapMap imputations including
7,892,440 markers with a MAF [ 0.01. There are minimal
differences in imputation quality when comparing the
2,972,940 SNPs common across the two datasets [mean
Rsq, 0.886 (median = 0.972, IQR = 0.123) for the Hap-
Map imputed dataset against 0.903 (median = 0.978,
IQR = 0.097) in the 1KG imputed dataset]. When further
filtering markers for MAF [ 0.01 and Rsq C 0.3, (result-
ing in 2,671,742 SNPs) the concordance rate, based on best
guess genotypes, between the Hapmap and the 1KG
imputed datasets was 0.983 as calculated by PLINK (using
the --merge-mode 7 option).
Fig. 3 Imputation quality metrics evaluation HapMap. a Boxplots of the MACH Rsq in function of the MAF of the imputed SNPs. b Imputation
quality distribution per MAF category. Blue and green denotes the poorly and well imputed SNPs based in a 0.3 quality score as threshold.
88,625 out of 3,021,329 (2.93 %) are poorly imputed SNPs (Rsq \ 0.3). (Color figure online)
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Correcting genome wide association analysis for ethnic
background in the Generation R Study
The socio-demographic ethnic definition in the Generation
R Study is based on country of birth of the parents of the
participants. To evaluate the degree of potential mis-
classification between definitions, we assessed the agree-
ment of the questionnaire definition with that of genetic
ancestry, using genomic components (Online Resource 7).
Groups classified as being of European and Dutch origin
have historically undergone high waves of migration dur-
ing the 1960s, 1970s or early 1980s. As a consequence, a
scattered distribution across the genomic components axes
was observed instead of a uniform one. A similar pattern
was also observed for participants of Surinamese origin,
arising from two clearly differentiated ethnic groups, the
Hindustani and the Creoles.
Statistical approaches based on EMMAX and genomic
components were tested for two different traits.). There is
no evidence of major degrees of residual population stra-
tification in the GWAS results for red hair color (Fig. 5 and
Online resource 8), within the Generation R Study (196
children with red hair (3.4 %) as gauged in the QQ-plots
(no early deviation from the test statistic or p value dis-
tribution) and genomic inflation factors (GIF) close to unity
for both EMMAX (GIF = 0.994) and genomic
Fig. 4 Imputation Quality metrics evaluation 1KG. a Boxplots of the MACH Rsq in function of the MAF of the imputed SNPs. b Imputation
quality distribution per MAF category. Blue and green denotes the poorly and well imputed SNPs based in a 0.3 quality score as threshold.
8,263,752 out of 30,072,738 (27.4 %) are poorly imputed SNPs (Rsq \ 0.3)
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components correction (GIF = 0.999). In contrast, when
no adjustment for population stratification was employed,
very early (artefactual) deviation was seen in the QQ plot,
erroneously indicating that the vast majority of markers
across the genome were associated with red hair pigmen-
tation (Fig. 5). After correction for population stratifica-
tion, only the markers on chromosome 16q24.3 mapping in
the vicinity of MCR1 reached GWS, variants in this gene
largely explain the presence of red hair pigmentation [28].
GWAS based on the imputed data gave rise to similar
results, but showed an even higher number of SNPs
underlying the MCR1 associated signal. Furthermore, the
leading SNP on these analyses was a missense variant
rs1805007, P \ 1 9 10-20, reported previously as asso-
ciated with this trait [29], which was not present in the
genotyped data (Online Resource 9). QQ-plots from the
skull BMD GWAS show adequate correction for popula-
tion stratification (Online Resource 10). Power for both
EMMAX and genomic components is similar in the two
tested traits, as gauged by the number of GWS signals and
their significant level (Online resources 8 and 11). More-
over the effect size of skull BMD associated SNPs is
practically identical across the two approaches.
Skull BMD analysis for equal sets of European and
Non-European children shows a GWS signal in the
WNT16/CPED1 locus only in the Non-European children,
although similar direction for the leading SNPs was found
in both sets (Online Resource 12). We compared the
association results for rs13223036 in this locus. The fre-
quency of the effect allele in Europeans was 0.622, while it
was 0.695 in non-Europeans. The effect size differed by
*27 % of the effect size in the European group (b = 0.15,
P = 6.8 9 10-6), being stronger and more significant in
the non-European set (b = 0.19, P = 2.5 9 10-8).
Discussion
In summary, we have described the methodology used to
genotype, impute, and analyze data for association with
phenotypes in the multiethnic Generation R Study, addres-
sing a number of practical issues that arise in implementing
imputation-based association for a multiethnic cohort.
Our genome-wide genotyped data, ready for analysis
after quality control (QC), comprises information for
518,245 markers in 5732 individuals of different ethnic
backgrounds, which is available in the most common
genome builds (i.e. 36 and 37). Enrichment by imputation
of our genotypes, following a cosmopolitan approach,
resulted in an increment of the number of markers of about
Fig. 5 Genome-wide association of red-hair pigmentation in the
Generation R cohort. a Q–Q plot showing the inflation of the test
statistics when correction for data structure is not applied (black dots)
and the slightly lower power when genomic components correction is
applied (red dots) in comparison with the EMMAX model (green
dots). b Manhattan plots of the red-hair pigmentation GWAS in the
Generation R Study using adjustment for genomic components.
c Manhattan plots of the red-hair pigmentation GWAS in the
Generation R Study using a linear mixed model as implemented in
EMMAX. (Color figure online)
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5.7 times for the HapMap imputed data and 46 times for
the 1KG imputed data (Rsq [ 0.3).
The Generation R Study withholds a special setting
determined by the admixed nature of its population con-
fined within a restricted area. This encompasses analytical
challenges as well as opportunities to design genetic stu-
dies, which take advantage of such characteristics. A joint
analysis including all Generation R participants represents
a considerable increase in power of the design, as about
half of the study population is of non-Northwestern Eur-
opean background. While, increment in sample size will in
principle boost the power of the study, differences in allele
frequency or LD relationships between the variants merit
further interpretation, as shown in the example of skull
BMD with equal number of individuals for both European
and non-European sets. Decrease in power due to the use of
an admixed population can appear when the association is
confined to one of the subpopulations (especially if small)
either because of differential tagging or due to the effect of
secondary signals [30].
GWAS meta-analyses are expanding to include Non-
European populations (i.e. Latinos, African-Americans,
etc.) with adequate methodology lagging behind due to
scarce available software for the processing and analysis
of multiethnic data. For example, as the most used soft-
ware, PLINK [13], relies on the assumption of homo-
geneous populations it cannot be applied directly to
establish family relatedness in multiethnic cohorts.
PLINK routine results in an overestimation of relatedness
between ancestrally similar individuals. Alternatively,
REAP [16] employs a routine that considers the presence
of more than one ancestral population and accounts for it
in the calculation of IBD probabilities. Nevertheless, in
our range of interest for QC purposes—greater than sec-
ond degree relatives—we found no misclassification of
the degree of relationship in the samples. Yet,
in situations where high sensitivity is required (e.g. for
the assessment of distant relatedness and/or fine pedigree
structure), REAP is recommended in studies with
admixed populations.
Choosing the optimal panel to impute the GWAS data
of a multiethnic population is critical. For the Generation
R Study, we have employed the so-called ‘‘cosmopolitan
approach’’, which has become the preferred approach
after the release of the 1000 Genomes Project panel [19].
Notably, nowadays all studies are being imputed to the
whole 1KG reference panel regardless of the background
of the population. Introducing such a combination of
reference panels, which achieve very large sample sizes
of sequencing reference sets, has been shown to improve
imputation accuracy [31–33]. This is mainly beneficial
for the imputation of rare variants, which have probably
arisen recently and are highly population specific.
New denser reference panels for imputation are
becoming available achieving a better characterization of
human genetic variation [7, 19, 34]. The 1KG project
data significantly increased the genomic coverage pro-
viding more variants suitable to be analyzed in a new
phase of the GWAS era [19], with already few reports of
novel findings [6, 35, 36], yet to be embraced at a larger
scale. Despite the higher density of markers in the 1KG,
only *63 % of the markers achieved good quality as
compared to 97 % of the HapMap imputed markers.
Nonetheless, the low imputation performance observed in
1KG markers is a consequence of the large amount of
low-frequency and rare markers in the panel in low LD
with the tagging SNPs in the array, which are thus,
difficult to impute. When the analysis is limited to
common variants (MAF [ 0.05) present in both datasets
(n = 2,144,906) the imputation quality was somewhat
higher in the 1KG (mean Rsq = 0.954, median = 0.989,
IQR = 0.037) than the HapMap panel (mean
Rsq = 0.947, median = 0.986, IQR = 0.046), an slight
improvement reflecting better imputation arising from a
more dense set of markers and a larger reference panel.
Special methods for imputation of admixed populations
such as MACH-Admix, have also emerged [37], claiming
better performance in admixed population and should be
part of future studies.
Ethnic background, as assessed by questionnaire did not
match the distribution of the samples in the genomic com-
ponents, mainly because it does not allow for the identifi-
cation of the third generation participants, i.e. the grand
children of those who originally migrated to the country, and
thus groups together children that are genetically divergent
as shown in Online Resource 7. This comparison together
with analysis of different traits, indicate that the genetic
structure of studies, such as the Generation R Study, cannot
be accounted for by considering the ethnic group definitions
based on questionnaire data alone. Another practical
advantage when using genomic components to adjust
GWAS, is the possibility to include participants even when
no information of the parents’ country of origin is available.
Although in other studies this percentage might be larger, in
the population under study, \7 % of the information on
ethnicity from the questionnaire was missing. The ethnic
distribution of the remaining children is in agreement with
the ethnic demography of the city of Rotterdam [11] and thus
we found no evidence of a systematic non-response.
We chose red hair pigmentation as an example of a
highly stratified trait since it is more common in countries
in the north of Europe and selected against in Africa due
to higher sensitivity of its carriers to UV rays. As shown
in Fig. 5, if adjustment for population stratification is not
used, alleles with different frequencies in Africa and the
North of Europe would spuriously show an association
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with the trait. Instead our association results show that
both genomic components and linear mixed models stra-
tegies cope well with the substructure of the data and
yield similar results. This conclusion can also be derived
from the skull BMD GWAS, where even magnitude of
effect sizes can be reliably compared. Thus, across all
tested scenarios subtle differences emerged not justifying
the use of the more computational intensive EMMAX
approach. Tests done on other traits such as height,
fractional exhaled nitric oxide, site-specific BMD (total
body, skull, arms and legs) produced similar results using
EMMAX as those published before using genomic com-
ponents [21, 38, 39].
It is important to emphasize possible drawbacks of
both association strategies. Those of using EMMAX
include: (1) for discrete traits obtained betas cannot be
translated to odd ratios, given the statistical model applied
and (2) its requirement for PLINK files, prevents the use
of allelic dosages for analysis. On the other hand, since
genomic components are calculated based on the varia-
bility of the input data, it is important to generate specific
sets of components for particular subsets of the data when
working with structured populations. Moreover, while
using between two and four genomic components is
common practice, the number of genomic components
needed to control for population stratification is trait-
specific (i.e. dependent on the actual genetic architecture
of the trait) [40]. The GIF is an indicator of the degree of
inflation of the test statistic due to true signals, cryptic
relatedness, assay bias and/or population stratification.
Hence, assessment of the GIF is instrumental to determine
the needed number of genomic components to be used as
covariates in the models. This strategy is not confined to
admixed populations and should be assessed even in
homogenous populations. In the examples mentioned
above, both height and BMD needed up to ten genomic
components (data not shown) to reach an acceptable
GIF \ 1.1 [18].
Although the general problem of stratification, differ-
ential ethnic allele frequencies, has been successfully
addressed in our cohort by the use of genomic components
or linear mixed models, the ethnic differences in patterns of
correlation between the underlying casual variant and the
surrounding SNPs which are under study (LD), can still
induce to false-negative findings [41].
As single-center GWAS are usually underpowered, the
standard strategy in the field is meta-analysis, the com-
bination of results from multiple independent studies,
increasing sample size and reducing false-positive find-
ings. Frequently, pooling studies from ethnically diverse
populations within a single transethnic meta-analysis can
be challenging. To cope with this, specialized software
such as MANTRA, which allows effect size to vary
across different populations, has been developed [42]. The
same strategy could also be applied to multiethnic studies
such as Generation R, if clear boundaries between dif-
ferent ethnic groups forming part of the study population
could be established. However, this is not plausible in our
highly admixed population.
The complex structure of the Generation R Study, where
admixture of individuals cannot be easily discerned just by
assessing the combination of two ancestral populations,
constrains the application of admixture mapping, which is
an important limitation of our study. Further, in the current
setting of the Generation R Study, the small sample size
resulting from defining well characterized ethnic groups (of
non-European background) is insufficient to allow fine
mapping of variants underlying complex traits, typically
withholding weak genetic effects. Yet, with new approa-
ches being developed [39], this analytical methodology
should be further implemented.
The Generation R Study is unusual in the international
arena due to its size, age range, quality of data and long-
itudinal study design, but particularly due to its multiethnic
nature. These characteristics represent the main strengths
of the cohort, allowing among others, the generalizability
of findings and ethnic comparisons in epidemiological
research, although complex routines might be required for
genetic association analysis.
In summary, we have described the methods used for
generating the GWAS data of the Generation R Study, as
well as general strategies for imputation and analysis
within a multiethnic setting. Such strategies have allowed
the Generation R Study to take part in several consortia
and collaborations, which have successfully identified
genetic factors underlying an ample range of complex
traits.
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